<li>acetaminophen<p>acetaminophen increases effects of heparin by unknown mechanism. Minor/Significance Unknown.</p></li><li>acetaminophen iv<p>acetaminophen iv increases effects of heparin by unknown mechanism. Minor/Significance Unknown.</p></li><li>acetaminophen rectal<p>acetaminophen rectal increases effects of heparin by unknown mechanism. Minor/Significance Unknown.</p></li><li>alprostadil intracavernous/urethral<p>alprostadil intracavernous/urethral increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>aprotinin<p>aprotinin increases effects of heparin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>ceftaroline<p>ceftaroline increases effects of heparin by Other (see comment). Minor/Significance Unknown. 
Comment: Cephalosporins with a methylthiotetrazole (MTT) side ring (eg, cefotetan, cefoperazone) are more frequently associated with hypoprothrombinemic activity.</p></li><li>chlorella<p>chlorella decreases effects of heparin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.</p></li><li>demeclocycline<p>demeclocycline increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dexmethylphenidate<p>dexmethylphenidate increases effects of heparin by decreasing metabolism. Minor/Significance Unknown.</p></li><li>doxycycline<p>doxycycline increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>glyburide<p>glyburide increases effects of heparin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>lymecycline<p>lymecycline increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>mineral oil<p>mineral oil decreases levels of heparin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>minocycline<p>minocycline increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>nitroglycerin iv<p>nitroglycerin iv decreases effects of heparin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>oxytetracycline<p>oxytetracycline increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>protamine<p>protamine decreases effects of heparin by Other (see comment). Minor/Significance Unknown. 
Comment: This combination produces an insoluble salt.</p></li><li>quinidine<p>quinidine increases effects of heparin by decreasing metabolism. Minor/Significance Unknown.</p></li><li>tetracycline<p>tetracycline increases effects of heparin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>vasopressin<p>heparin decreases effects of vasopressin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>verteporfin<p>heparin decreases effects of verteporfin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>vitamin e<p>vitamin e, heparin. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Vitamin E at RDA does not change INR in pts. on chronic warfarin therapy; megadoses (~10x RDA) may enhance anticoagulant effects in vitamin K deficient pts.</p></li>